All News

CURE spoke with Dr. Rosario Ligestri and Dr. Anna Berkenblit about the rising rate of pancreatic cancer in relatively younger adults.

In October 2025, the FDA granted approval to multiple new cancer therapies and supportive care options, covering treatments across the oncologic landscape.

In honor of Pancreatic Cancer Awareness Month, we spoke with Dr. Rosario Ligresti about rising rates of the disease in younger adults and more.

I share how walking has helped me through lymphoma, knee surgeries and treatments, and why staying active keeps me physically, mentally and spiritually strong.

Stoboclo and Osenvelt is now interchangeable with brand-name drugs, per the FDA, letting pharmacists substitute them while ensuring safety and efficacy.

Dr. Dima El-Sharkawi discusses how hairy cell leukemia typically presents in patients and the challenges clinicians face in identifying the disease early.

Choosing treatment for stage 2 prostate cancer? Get the facts on surgery vs radiation and learn to manage possible side effects like erectile dysfunction.

Tamron Little was diagnosed with peritoneal mesothelioma after childbirth and now, 18 years later, she says survivorship is lifelong.

Participating in the SUNRiSE-1 trial taught Bill the value of education, teamwork, and persistence for patients with bladder cancer.

Cancer has taught me to be vigilant, but also to be grateful — for modern science, for watchdog organizations, for the ability to access information instantly.

Dr. Anjana Pillai says treatment depends on stage and health, with surgery, transplant, local therapy or systemic drugs to help people live longer.

An expert discusses why up to 60% of new trial sites close in year one and what this means for patient access and research supply.

It wasn’t that I never expected a breast cancer diagnosis, it was that I had never even considered a breast cancer diagnosis.

Dr. Vinayak Venkataraman recently sat down with CURE to discuss the evolving treatment landscape for gastrointestinal stromal tumors.

The U.S. FDA has granted orphan drug designation to DPTX3186, an investigational therapy being developed for gastric cancer treatment.

Bill joined the SUNRiSE-1 trial for Inlexzo, avoiding bladder removal, staying active and reaching full remission from BCG-unresponsive bladder cancer.

No diet, supplement or vaccine can take away all risk. But using proven approaches gives me a sense of control and confidence.

Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as gastrointestinal stromal tumor (GIST).

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as survivorship becomes a key focus.

Chester Freeman shares how the Japanese philosophy of wabi-sabi helped him embrace his scar and find beauty in imperfection while living with leukemia.

Three experts in breast surgery, medical oncology and reconstructive surgery share their insights on the importance of Breast Cancer Awareness Month.

The FDA granted fast track designation to JSKN003 in platinum-resistant recurrent epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer.

Scalp cooling helped Maureen Green feel more like herself during chemotherapy, giving her control over her appearance at a time filled with fear and uncertainty.

My first oncologist got me started with positivity in my cancer journey, which I was thankfully able to internalize.

During Liver Cancer Awareness Month, Dr. Anjana Pillai says more treatment options, growing trials and ongoing research offer hope for patients.

For Stephanie Wachtel, receiving a diagnosis of triple-positive breast cancer at the age of 23 was life-changing in a number of ways.

Therapies may affect ovarian function and cause early menopause, and many younger women can still pursue family planning with guidance from their care team.

Exousia Pro, Inc. received orphan drug designation from the FDA for malignant glioma, also known as glioblastoma multiforme or GBM.